N. Kotur

发表

6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner.

G. Patrinos, G. Nikčević, M. Stojiljkovic, 2012, Pharmacogenomics.

Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment

V. Gasic, B. Zukic, S. Pavlovic, 2019, Genes.

Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin

G. Patrinos, B. Zukic, M. Radmilovic, 2012, Annals of Hematology.

The pharmacogenomics of vincristine-induced peripheral neuropathy in pediatric acute lymphoblastic leukemia patients in Serbia - a single center experience

V. Gasic, B. Zukic, S. Pavlovic, 2021, Srpski arhiv za celokupno lekarstvo.

SIGNIFICANCE OF UGT 1 A 1 * 28 GENOTYPE IN PATIENTS WITH ADVANCED LIVER INJURY CAUSED BY CHRONIC HEPATITIS C ZNA

V. Gasic, B. Zukic, S. Pavlovic, 2018 .

Genetic predictors of celiac disease, lactose intolerance, and vitamin D function and presence of peptide morphins in urine of children with neurodevelopmental disorders

V. Gasic, B. Zukic, S. Pavlovic, 2017, Nutritional neuroscience.

New PAH gene promoter KLF1 and 3′-region C/EBPalpha motifs influence transcription in vitro

V. Spasovski, G. Nikčević, M. Stojiljkovic, 2017, Journal of Applied Genetics.

Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population

V. Gasic, B. Zukic, B. Stankovic, 2022, Frontiers in Genetics.

INFLUENCE OF PROMOTER POLYMORPHISMS OF THE TNF-a (-308G/A) AND IL-6 (-174G/C) GENES ON THERAPEUTIC RESPONSE TO ETANERCEPT IN RHEUMATOID ARTHRITIS UTICAJ POLIMORFIZAMA TNF-a (-308G/A) I IL-6 (-174G/C) GENA NA TERAPIJSKI ODGOVOR NA ETANERCEPT U REUMATOIDNOM ARTRITISU

V. Spasovski, N. Damjanov, N. Kotur, 2015 .

Influence of Promoter Polymorphisms of the TNF-α (-308G/A) and IL-6 (-174G/C) Genes on Therapeutic Response to Etanercept in Rheumatoid Arthritis

V. Spasovski, S. Pavlovic, N. Damjanov, 2015, Journal of medical biochemistry.

Clinical application of thiopurine pharmacogenomics in pediatrics.

V. Gasic, B. Zukic, S. Pavlovic, 2020, Current drug metabolism.

HLA genotyping in pediatric celiac disease patients.

G. Nikčević, B. Zukic, S. Pavlovic, 2014, Bosnian journal of basic medical sciences.

Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease

B. Stankovic, A. Milutinović, Tamara Milovanovic, 2022, Life.

Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

V. Gasic, B. Zukic, S. Pavlovic, 2019, Journal of medical biochemistry.

TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner.

G. Patrinos, T. Katsila, N. Tosic, 2015, Pharmacogenomics.

Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study.

S. Pavlovic, B. Stankovic, T. Milosavljevic, 2018, Clinical immunology.

Cytotoxicity of the gold complex based on mercaptotriazole – A comparison with the conventional cyanide electrolyte

S. Dimitrijević, N. Kotur, S. Alagić, 2021, Journal of the Indian Chemical Society.

The in vitro antioxidative and cytotoxic effects of selected Salvia species water extracts

P. Marin, S. Duletić-Laušević, V. Matevski, 2015 .

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations

V. Gasic, M. Stojiljkovic, B. Zukic, 2020, Journal of medical biochemistry.

Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications

V. Gasic, G. Nikčević, B. Zukic, 2021, Genes.

Metabolic Syndrome in Inflammatory Bowel Disease: Association with Genetic Markers of Obesity and Inflammation.

S. Pavlovic, T. Milosavljevic, Tamara Milovanovic, 2019, Metabolic syndrome and related disorders.

Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment

V. Gasic, B. Zukic, S. Pavlovic, 2020, Genes.

Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrence

G. Nikčević, B. Zukic, S. Pavlovic, 2015, Journal of digestive diseases.

UGT1A1 (TA)n Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia

V. Gasic, M. Stojiljkovic, B. Zukic, 2018, Balkan journal of medical genetics : BJMG.

Influence of variants in folate metabolism genes on 6-mercaptopurine induced toxicity during treatment for childhood acute lymphocytic leukemia.

B. Zukic, S. Pavlovic, V. Jurišić, 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Wilms tumor (WT)1 gene expression in children with acute leukemia in Serbia

N. Tosic, S. Pavlovic, D. Janić, 2016 .

Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity

V. Gasic, B. Zukic, S. Pavlovic, 2021, Frontiers in Nutrition.

Pharmacogenomics and Pharmacotranscriptomics of Glucocorticoids in Pediatric Acute Lymphoblastic Leukemia

V. Gasic, B. Zukic, S. Pavlovic, 2021, Corticosteroids [Working Title].

Pharmacogenomic Markers of Glucocorticoid Response in The Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

V. Gasic, B. Zukic, S. Pavlovic, 2018, Radiology and oncology.

Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection

V. Gasic, M. Stojiljkovic, B. Zukic, 2020, bioRxiv.

Variants in TPMT, ITPA, ABCC4 and ABCB1 Genes As Predictors of 6-mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia

G. Patrinos, T. Katsila, B. Zukic, 2018, Journal of medical biochemistry.

Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease

G. Nikčević, B. Zukic, S. Pavlovic, 2017, European journal of gastroenterology & hepatology.

Importance of pharmacogenetic markers in the methylenetetrahydrofolate reductase gene during methotrexate treatment in pediatric patients with acute lymphoblastic leukemia

B. Zukic, S. Pavlovic, M. Životić, 2017 .

Micronutrients, genetics and COVID-19

N. Kotur, Sonja Pavlović, B. Stanković, 2023, Current opinion in clinical nutrition and metabolic care.

Kluwe EVIDENCE FROM NUTRIGENETIC STUDIES OF MICRONUTRIENTS IN CORONAVIRUS DISEASE 2019

N. Kotur, Sonja Pavlović, B. Stanković, 2023 .

IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury.

V. Gasic, B. Zukic, S. Pavlovic, 2019, Journal of infection in developing countries.

Significance of UGT1A1*28 Genotype in Patients with Advanced Liver Injury Caused By Chronic Hepatitis C

V. Gasic, B. Zukic, S. Pavlovic, 2018, Journal of medical biochemistry.

Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?

V. Spasovski, B. Zukic, N. Damjanov, 2023, International journal of molecular sciences.

Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy.

G. Nikčević, B. Zukic, S. Pavlovic, 2020, Pathology, research and practice.

Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease.

B. Zukic, S. Pavlovic, A. Ventura, 2018, Current medicinal chemistry.